Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/1999
03/30/1999US5889165 Photolabile nucleoside protecting groups
03/30/1999US5889160 Human IL-2 receptor γ-chain molecule antibody
03/30/1999US5889159 Monoclonal antibodies to tumor marker TC1 and methods for use of same
03/30/1999US5889145 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889136 Phosphoramidite oligonucleotide biosynthesis
03/30/1999US5888982 Regulation of vascular smooth muscle cell heme oxygenase-1
03/30/1999US5888965 Method of stimulating bone marrow regeneration
03/30/1999US5888828 Contining a-ketoglutaric acid and nicotineamide adenine dinucleotide
03/30/1999US5888827 Method for determination of cholesterol in low-density lipoprotein or very low-density lipoprotein
03/30/1999US5888824 Blood test ware and matrixes
03/30/1999US5888820 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
03/30/1999US5888819 Method for determining nucleotide identity through primer extension
03/30/1999US5888812 Myeloid cell leukemia associated gene MCL-1
03/30/1999US5888808 Bacterial polypeptide expression employing tryptophan promoter-operator
03/30/1999US5888801 Bacillus thuringiensis
03/30/1999US5888798 Proteus vulgaris which produce enzymes without exogenous inducer
03/30/1999US5888780 Using enzymes
03/30/1999US5888779 Genetic engineering
03/30/1999US5888778 Diagnosis of colorectal cancer
03/30/1999US5888770 Spoiiie
03/30/1999US5888764 Human fas gene promoter region
03/30/1999US5888760 Universal test systems and methods of use thereof for identifying multiple families of microorganisms
03/30/1999US5888757 Screening for fungicides
03/30/1999US5888755 Method of determining the amount of cholesterol in a high-density lipoprotein
03/30/1999US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
03/30/1999US5888741 Computer-based design and screening of molecules using DNA interactions
03/30/1999US5888740 Prenatal detection; does not require size separation, instead uses hydridization and colormetric screening; tightly controlled internal standards for comparing gene dosage by placing one copy of chromosomal markers on one plasmid
03/30/1999US5888739 Fluorescence analysis
03/30/1999US5888738 Design of drugs involving receptor-ligand-DNA interactions
03/30/1999US5888737 Forming target polynucleotide-adaptor adduct to solve problems created by self-ligation of polynucleotides that have complementary ends
03/30/1999US5888736 Method, compositions and kit for detection and identification of microorganisms
03/30/1999US5888735 Cancer drug screen based on cell cycle uncoupling
03/30/1999US5888734 Chromosomal targets, without any chemical or physical denaturing pretreatment, probes, and aqueous buffer are mixed together into close spatial contact for initiating hybridization under non-denaturing conditions; simple, fast
03/30/1999US5888733 In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples
03/30/1999US5888731 Combining sample with three species of oligonucleotide probes under hybridization conditions, ligating hybridized probes, evaluating products
03/30/1999US5888730 Determination either directly or indirectly of the presence of the y chromosome in a particular tissue sample.
03/30/1999US5888729 Oligonucleotide probes and methods for detecting Streptococcus pneumoniae
03/30/1999US5888728 Filtration of solution of sample dna and two sets of single stranded binding proteins or complementary oligonucleotide probes with avidin or label attached, forming complex with biotinylated hapten on membrane, thus localizing complex
03/30/1999US5888725 Method for identifying target bacteria
03/30/1999US5888724 Detection of high oncogenic-risk papilloma virus in high grade cervical lesions and cancers by a PCR/ELISA assay
03/30/1999US5888723 Sensitive hybridization assay using nucleic acid reagent composed of oligonucleotides covalently attached to polymer particles which are adhered to support using water insoluble adhesive; low background
03/30/1999US5888721 Novel antibiotics, termed 15352a and 15352b, obtained from cultures of thielavia terracola
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888498 Cellular and animal models for diseases associated with mitochondrial defects
03/30/1999US5888248 Dermal-epidermal in vitro test system
03/30/1999CA2217097A1 Molecular diagnostic of glaucomas associated with chromosomes 2 and 6
03/30/1999CA2216997A1 Molecular diagnostic of glaucomas associated with chromosomes 1
03/30/1999CA2160916C Test composition for the rapid detection of helicobacter pylori in gastric biopsy tissue
03/25/1999WO1999014596A1 Capacity affinity sensor
03/25/1999WO1999014377A2 Detection and identification of human papillomavirus by pcr and type-specific reverse hybridization
03/25/1999WO1999014376A2 Detection of aneuploidy and gene deletion by pcr-based gene-dose co-amplification of chromosome specific sequences with synthetic internal controls
03/25/1999WO1999014375A2 Dna typing by mass spectrometry with polymorphic dna repeat markers
03/25/1999WO1999014374A2 Methods for determining genetic susceptibility to diabetic nephropathy
03/25/1999WO1999014373A1 Method for selection of insertion mutations
03/25/1999WO1999014372A1 Reagents and methods useful for detecting diseases of the urinary tract
03/25/1999WO1999014371A1 Dna bracketing locus compatible standards for electrophoresis
03/25/1999WO1999014370A1 De novo polynucleotide synthesis using rolling templates
03/25/1999WO1999014369A1 Techniques for identifying, confirming, mapping and categorizing polymers
03/25/1999WO1999014367A1 Method for determining propensity for developing late-onset alzheimer's disease
03/25/1999WO1999014366A2 Detection of minimal residual disease in lymphoid malignancies
03/25/1999WO1999014365A1 The porcine adipocyte fatty acid-binding protein encoding gene and methods to localise, identify or mark genes or alleles or quantitative trait loci of farm animals
03/25/1999WO1999014363A1 Genetic polymorphisms in the microsomal triglyceride transfer protein promoter and uses thereof
03/25/1999WO1999014362A1 Characterising nucleic acid by mass spectrometry
03/25/1999WO1999014361A1 Hybridization probes which differentiate between streptomycetes and maduromycetes
03/25/1999WO1999014360A1 Improved detection method for premature termination mutations
03/25/1999WO1999014359A1 Method of monitoring the competitiveness of a microbial strain
03/25/1999WO1999014358A1 Chemiluminescence compositions and methods
03/25/1999WO1999014357A2 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
03/25/1999WO1999014356A2 P53-induced apoptosis
03/25/1999WO1999014355A2 Highly affine nucleic acid molecules, production and application of same
03/25/1999WO1999014352A2 Assay for identifying compounds modulating the expression of glucose-6-phosphatase
03/25/1999WO1999014344A1 G protein chimeras
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014336A2 Thermostable luciferases and methods of production
03/25/1999WO1999014331A2 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014319A1 An improved yeast interaction trap assay
03/25/1999WO1999014317A1 Methods for the diagnosis of feline infectious anemia
03/25/1999WO1999014315A1 Interference free biosensor
03/25/1999WO1999014311A1 Method of screening for antimicrobial compounds
03/25/1999WO1999014310A1 Rna export element and methods of use
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014237A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999WO1999014235A1 Persephin and related growth factors
03/25/1999WO1999014228A1 Genetic compositions and methods
03/25/1999WO1999014226A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013719A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999WO1999008091B1 System and method for automatically detecting malignant cells and cells having malignancy-associated changes
03/25/1999WO1999002735A3 Diagnostic assays and kits for body mass and cardiovascular disorders
03/25/1999WO1999001572A3 Methods for rapidly detecting methicillin resistant staphylococci
03/25/1999WO1999001571A3 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions
03/25/1999WO1999001569A3 Additives for use in cycling probe reactions
03/25/1999WO1999000654A3 Radiolabeled farnesyl-protein transferase inhibitors
03/25/1999WO1998057994A3 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/25/1999WO1998055509A3 Two human dnaj-like proteins
03/25/1999WO1998051819A9 Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors